SHARE BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2016

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of Stock Option Activity

	Number of				Weighted-average
	option		Weighted-average		remaining		Aggregate
	outstanding		exercise price		contractual term		intrinsic value
			(US$/share)		(in years)		(RMB)
Balance as of January 1, 2016		14,627,422		4.77
Granted		1,760,000		3.29
Exercise		(1,259,336)		2.07
Forfeited		(472,000)		3.19
Balance as of December 31, 2016		14,656,086		3.11		6.47		75,543,554
Vested and expected to vest as of December 31, 2016		10,301,274		3.04		5.66		59,982,288
Vested and exercisable as of December 31, 2016		7,268,086		2.92		4.80		49,148,244

Summary of Non-vested Shares

	Number of option		Weighted-average fair
	outstanding		value on grant date (RMB/Share)
Non-vested at January 1, 2016		9,152,000		26.52
Granted		1,760,000		17.48
Vested		(3,244,000)		20.89
Forfeited		(280,000)		24.17
Non-vested at December 31, 2016		7,388,000		14.97
Expected to vest as of December 31, 2016		3,033,188		14.52

Schedule of Expense Allocation

	As of December 31,
	2014		2015		2016
	RMB		RMB		RMB
Costs of revenues		203,140		118,301		333,338
Selling expenses		6,397,902		23,625,827		15,980,509
General and administrative expenses		34,164,506		81,024,667		67,152,462
Research and development expenses		1,924,447		7,945,590		6,101,390
Total		42,689,995		112,714,385		89,567,699

Schedule of Assumptions

	2014			2015			2016
Expected volatility		93.29	%		83.49% - 91.68%			77.72% - 79.56%
Expected dividend yield		0	%		0	%		0	%
Expected terms		6.5			6.5			5.3 - 6.5
Risk-free interest rate		1.93	%		1.50% - 1.74%			1.74% - 1.94%
Fair value per option at grant date (RMB)		28.42			25.62 – 35.31			16.94 - 17.93

JinkoSolar Power [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Assumptions

	2015
Expected volatility		53.56	%
Expected dividend yield		0	%
Option term		10 years
Risk-free interest rate		2.36	%
Expected forfeiture rate (post-vesting)		0% or 10%
Fair value per option at grant date (USD)		1.88-2.01